Genetic polymorphism in CYP17 and breast cancer risk in Japanese women

European Journal of Cancer

Volumn 36, Issue 18, 2000, Pages 2375-2379

  Miyoshi, Y ^a   Iwao, K ^a   Ikeda, N ^a   Egawa, C ^a   Noguchi, S ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Breast cancer; CYP17; Oestrogen; Polymorphism

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 C17ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; JAPAN; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE;

EID: 0033679658     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00334-8     Document Type: Article

References (20)

1. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: Associations and interactions in an international case-control study
2. Breast cancer epidemiology: Summary and future directions
3. A systematic review of genetic polymorphisms and breast cancer risk
4. Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells
5. A polymorphism in the CYP17 gene increases the risk of breast cancer
6. Association between CYP17 gene polymorphism and risk of breast cancer in young women
7. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17
8. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations
9. No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer
10. CYP17 genotype and breast cancer risk
11. Association between CYP17 polymorphisms and the development of breast cancer
12. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer
13. Allele detection and population study in Japanese using two STR loci (CYP19 and HUMTH01)
14. Combined polymorphism associated with a 3-bp deletion in the 5'-flanking region of a tetrameric short tandem repeat at the CYP19 locus
15. Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk
16. Determination of intratumoral estrone (E1) and estradiol (E2) in primary breast cancer tissues by sensitive HPLC-RIA
17. Metabolism of pregnenolone by human breast cancer, evidence for 17α-hydroxylase and 17,20-lyase
18. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility
19. CYP17 and breast cancer risk: The polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1